Correlations between intravoxel incoherent motion-derived fast diffusion and perfusion fraction parameters and VEGF-

Yaru Sheng1, Xuefei Dang2, Hua Zhang3

  • 1Radiology Department of Huashan Hospital, Fudan University, Shanghai, 200040, China.

European Radiology
|March 21, 2023
PubMed
Abstract

Insights

Intravoxel incoherent motion-diffusion-weighted imaging (IVIM-DWI) fast diffusion (Dfast) and perfusion fraction (PF) correlate with glioma malignancy markers. Optimized IVIM-DWI parameters show promise for non-invasively assessing tumor characteristics like angiogenesis and proliferation.

Area of Science:

  • Radiology and Imaging Science
  • Neuro-oncology
  • Biomedical Engineering

Background:

  • Brain gliomas are complex tumors requiring accurate assessment of malignancy.
  • Histopathologic findings are crucial but invasive; non-invasive imaging biomarkers are needed.
  • Intravoxel incoherent motion (IVIM)-diffusion-weighted imaging (DWI) offers insights into tissue microstructures.

Purpose of the Study:

  • To investigate correlations between histopathologic findings and IVIM-derived parameters in brain gliomas.
  • To assess the potential of IVIM-DWI parameters to reflect tumor characteristics such as vascularity and proliferation.

Main Methods:

  • Retrospective analysis of 32 biopsy samples from 21 glioma patients.
  • Diffusion-weighted MRI with 22 b values (0-5000 s/mm²) followed by biopsy.
  • Immunohistochemical analysis for cell density, MIB-1 (Ki67), CD34-MVD, and VEGF; correlation with IVIM parameters (Dfast, Dslow, PF).

Main Results:

  • Significant positive correlations found between Dfast (at 1500 and 5000 s/mm²) and percent VEGF (pVEGF).
  • Significant negative correlation observed between PF (at 5000 s/mm²) and percent MIB-1 (pMIB-1).
  • Moderate to good positive correlations noted between Dfast (at 1500 and 5000 s/mm²) and glioma grades.

Conclusions:

  • IVIM-DWI-derived Dfast and PF quantitatively correlate with intratumor pVEGF and pMIB-1, respectively.
  • Optimized IVIM-DWI schemes, particularly with higher b values, enhance evaluation of glioma malignancy.
  • IVIM-derived Dfast5000 and PF5000 show promise as non-invasive biomarkers for assessing glioma angiogenesis and proliferation.